Lebrikizumab Biosimilar - Ultra Low Endotoxin

Lebrikizumab Biosimilar - Ultra Low Endotoxin

• Specifications: Detects human IL-13. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Lebrikizumab.
• Species Reactivity: Human
• Target: IL-13
• Applications: Functional Assays
• Purification Method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
• Concentration: 5mg/mL
• Endotoxin: ≤ 0.1 EU/mg as determined by the LAL method
• Purity: >95% by SDS-PAGE
• Buffer: ICH3002
• Storage Conditions: This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
• Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.
• Isotype Control: https://ichor.bio/product/bulk-human-igg4-isotype-control-s228p-ib4-ich2257s228p/